Cargando…

Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo

INTRODUCTION: In Japan, patients with coronavirus disease 2019 (COVID-19) who do not require medical intervention are provided care in recovery accommodation facilities (RAFs). However, some patients may require hospitalization if their symptoms become more severe during their stay. We conducted an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Yohei, Satoh, Kenichi, Tanaka, Takuma, Yamaguchi, Takayuki, Miyamoto, Tomomi, Sawaki, Kenji, Miyajima, Makiko, Nakaharai, Kazuhiko, Hoshina, Tokio, Horino, Tetsuya, Nakazawa, Yasushi, Ikenoue, Tatsuyoshi, Yoshida, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189095/
https://www.ncbi.nlm.nih.gov/pubmed/35717438
http://dx.doi.org/10.1016/j.jiac.2022.06.002
_version_ 1784725507854565376
author Sakamoto, Yohei
Satoh, Kenichi
Tanaka, Takuma
Yamaguchi, Takayuki
Miyamoto, Tomomi
Sawaki, Kenji
Miyajima, Makiko
Nakaharai, Kazuhiko
Hoshina, Tokio
Horino, Tetsuya
Nakazawa, Yasushi
Ikenoue, Tatsuyoshi
Yoshida, Masaki
author_facet Sakamoto, Yohei
Satoh, Kenichi
Tanaka, Takuma
Yamaguchi, Takayuki
Miyamoto, Tomomi
Sawaki, Kenji
Miyajima, Makiko
Nakaharai, Kazuhiko
Hoshina, Tokio
Horino, Tetsuya
Nakazawa, Yasushi
Ikenoue, Tatsuyoshi
Yoshida, Masaki
author_sort Sakamoto, Yohei
collection PubMed
description INTRODUCTION: In Japan, patients with coronavirus disease 2019 (COVID-19) who do not require medical intervention are provided care in recovery accommodation facilities (RAFs). However, some patients may require hospitalization if their symptoms become more severe during their stay. We conducted an observational study using epidemiological data of patients with COVID-19 admitted to RAFs in Tokyo. METHODS: This was an observational cohort study using data from COVID-19 patients admitted to one of the RAFs in Tokyo from December 2020 to November 2021. Admissions to the facilities were limited to patients with asymptomatic or mild COVID-19 with no underlying disease or at least stable underlying disease at the time of admission. Patients were hospitalized when they required oxygen administration or when they had, or persistent fever, or severe respiratory symptoms. We evaluated the association between hospitalization and the risk factors for hospitalization using a Cox regression model. RESULTS: The number of patients with COVID-19 admitted to the RAF was 6176. The number of hospitalized patients was 393 (6.4%), and the median length of stay was 5.50 days (IQR: 4.50, 6.50). In the Cox regression analysis, the hazard ratio increased with age and was significantly higher among patients aged >60 years (HR = 10.23, 95% CI: 6.72–15.57) than those in other age groups. This trend is similar to that observed in the sensitivity analysis. CONCLUSION: Patients with diabetes, the elderly, obesity, and medications for gout and psychiatric diseases may be at a high risk of hospitalization. In particular, an age over 60 years was strongly associated with hospitalization.
format Online
Article
Text
id pubmed-9189095
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-91890952022-06-13 Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo Sakamoto, Yohei Satoh, Kenichi Tanaka, Takuma Yamaguchi, Takayuki Miyamoto, Tomomi Sawaki, Kenji Miyajima, Makiko Nakaharai, Kazuhiko Hoshina, Tokio Horino, Tetsuya Nakazawa, Yasushi Ikenoue, Tatsuyoshi Yoshida, Masaki J Infect Chemother Note INTRODUCTION: In Japan, patients with coronavirus disease 2019 (COVID-19) who do not require medical intervention are provided care in recovery accommodation facilities (RAFs). However, some patients may require hospitalization if their symptoms become more severe during their stay. We conducted an observational study using epidemiological data of patients with COVID-19 admitted to RAFs in Tokyo. METHODS: This was an observational cohort study using data from COVID-19 patients admitted to one of the RAFs in Tokyo from December 2020 to November 2021. Admissions to the facilities were limited to patients with asymptomatic or mild COVID-19 with no underlying disease or at least stable underlying disease at the time of admission. Patients were hospitalized when they required oxygen administration or when they had, or persistent fever, or severe respiratory symptoms. We evaluated the association between hospitalization and the risk factors for hospitalization using a Cox regression model. RESULTS: The number of patients with COVID-19 admitted to the RAF was 6176. The number of hospitalized patients was 393 (6.4%), and the median length of stay was 5.50 days (IQR: 4.50, 6.50). In the Cox regression analysis, the hazard ratio increased with age and was significantly higher among patients aged >60 years (HR = 10.23, 95% CI: 6.72–15.57) than those in other age groups. This trend is similar to that observed in the sensitivity analysis. CONCLUSION: Patients with diabetes, the elderly, obesity, and medications for gout and psychiatric diseases may be at a high risk of hospitalization. In particular, an age over 60 years was strongly associated with hospitalization. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022-10 2022-06-13 /pmc/articles/PMC9189095/ /pubmed/35717438 http://dx.doi.org/10.1016/j.jiac.2022.06.002 Text en © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Note
Sakamoto, Yohei
Satoh, Kenichi
Tanaka, Takuma
Yamaguchi, Takayuki
Miyamoto, Tomomi
Sawaki, Kenji
Miyajima, Makiko
Nakaharai, Kazuhiko
Hoshina, Tokio
Horino, Tetsuya
Nakazawa, Yasushi
Ikenoue, Tatsuyoshi
Yoshida, Masaki
Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo
title Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo
title_full Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo
title_fullStr Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo
title_full_unstemmed Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo
title_short Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo
title_sort risk factors associated with hospitalization in patients with asymptomatic or mild covid-19 in public accommodation facilities in tokyo
topic Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189095/
https://www.ncbi.nlm.nih.gov/pubmed/35717438
http://dx.doi.org/10.1016/j.jiac.2022.06.002
work_keys_str_mv AT sakamotoyohei riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT satohkenichi riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT tanakatakuma riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT yamaguchitakayuki riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT miyamototomomi riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT sawakikenji riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT miyajimamakiko riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT nakaharaikazuhiko riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT hoshinatokio riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT horinotetsuya riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT nakazawayasushi riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT ikenouetatsuyoshi riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo
AT yoshidamasaki riskfactorsassociatedwithhospitalizationinpatientswithasymptomaticormildcovid19inpublicaccommodationfacilitiesintokyo